NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 2B35 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
2B35_NAD_A_301 | 53% | 16% | 0.148 | 0.908 | 1.83 | 1.86 | 5 | 8 | 1 | 0 | 100% | 1 |
2B35_NAD_B_303 | 50% | 16% | 0.146 | 0.895 | 1.81 | 1.87 | 6 | 7 | 0 | 0 | 100% | 1 |
2B35_NAD_E_310 | 49% | 15% | 0.15 | 0.895 | 1.75 | 2.02 | 4 | 9 | 2 | 0 | 100% | 1 |
2B35_NAD_D_307 | 42% | 16% | 0.162 | 0.881 | 1.79 | 1.92 | 5 | 9 | 2 | 0 | 100% | 1 |
2B35_NAD_C_305 | 38% | 19% | 0.161 | 0.862 | 1.91 | 1.57 | 6 | 5 | 0 | 0 | 100% | 1 |
2B35_NAD_F_312 | 34% | 20% | 0.198 | 0.884 | 1.77 | 1.65 | 5 | 3 | 2 | 0 | 100% | 1 |
2X23_NAD_A_1270 | 100% | 24% | 0.045 | 0.992 | 1.42 | 1.68 | 5 | 9 | 0 | 0 | 100% | 1 |
4TZK_NAD_A_500 | 99% | 63% | 0.058 | 0.988 | 0.64 | 0.79 | - | 1 | 0 | 0 | 100% | 0.99 |
4D0S_NAD_C_1270 | 99% | 62% | 0.054 | 0.982 | 0.69 | 0.76 | - | 1 | 0 | 0 | 100% | 1 |
5MTR_NAD_E_301 | 99% | 37% | 0.057 | 0.984 | 1.39 | 1.11 | 3 | 5 | 1 | 0 | 100% | 1 |
5OIC_NAD_A_301 | 98% | 64% | 0.062 | 0.986 | 0.57 | 0.79 | - | 1 | 0 | 0 | 100% | 1 |
3CMC_NAD_R_408 | 100% | 20% | 0.016 | 0.998 | 1.63 | 1.74 | 4 | 9 | 0 | 0 | 100% | 1 |
4RQU_NAD_B_403 | 100% | 3% | 0.019 | 0.997 | 3.51 | 2.61 | 13 | 18 | 0 | 0 | 100% | 1 |
3EC7_NAD_A_400 | 100% | 18% | 0.025 | 0.995 | 1.8 | 1.74 | 5 | 8 | 1 | 0 | 100% | 1 |
4URF_NAD_A_1249 | 100% | 44% | 0.034 | 0.995 | 0.96 | 1.2 | 2 | 4 | 0 | 0 | 100% | 1 |
2C5A_NAD_B_1374 | 100% | 23% | 0.039 | 0.992 | 1.34 | 1.84 | 6 | 7 | 1 | 0 | 100% | 1 |